Key Market Indicators
Sales of digestive system medicines in Slovakia are expected to reach $290.6 million by 2026. This is an increase of 2.2% year-on-year, and has been growing at an average rate of 4.2% since 2000. In 2021, Slovakia was ranked 21st in digestive system medicine sales, with Ireland overtaking them at $252.6 million. Japan, South Korea and Canada ranked 2nd, 3rd and 4th respectively.